Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26F1PQQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,326
Award facts
- Contract value 100% obligated
- $1,325.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,325.96 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens. This competitive award, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the distributor to supply medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its extensive portfolio of pharmaceutical deliveries to the Defense Health Agency and other government healthcare systems. Repatha is a PCSK9 inhibitor used for cholesterol management and represents the type of specialty pharmaceutical product that AmerisourceBergen regularly distributes through its federal contracts. The company's federal contract awards demonstrate consistent capability to meet competitive procurement requirements across a broad spectrum of therapeutic domains, from specialty medications to vaccines and medical devices, supporting military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26F1PQQ?
SPE2DR26F1PQQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F1PQQ worth?
The government has obligated $1,326 on SPE2DR26F1PQQ.
Is contract SPE2DR26F1PQQ an order under another contract?
Yes. SPE2DR26F1PQQ is a delivery order under SPE2DR25D3108, an indefinite delivery contract.
Was contract SPE2DR26F1PQQ competed?
The extent of competition for SPE2DR26F1PQQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award